Cartesian Therapeutics, Inc. (RNAC) Total assets 2016–2025
Cartesian Therapeutics, Inc. (RNAC) total assets at each fiscal year-end, per SEC filings.
$296.4MFY2025 · since FY2016: $89.3M → $296.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $296.4M | -31.9% |
| FY2024 | $435.0M | +42.6% |
| FY2023 | $305.1M | +83.9% |
| FY2022 | $165.9M | +3.8% |
| FY2021 | $159.9M | -3.4% |
| FY2020 | $165.4M | +66.2% |
| FY2019 | $99.6M | +123.8% |
| FY2018 | $44.5M | -56.0% |
| FY2017 | $101.1M | +13.2% |
| FY2016 | $89.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RNAC financial trends
RNAC RevenueRNAC Net incomeRNAC Net marginRNAC Gross profitRNAC Gross marginRNAC Operating incomeRNAC Operating marginRNAC Operating cash flowRNAC Free cash flowRNAC Capital expendituresRNAC Return on equityRNAC Stock buybacksRNAC Dividends paidRNAC Total liabilitiesRNAC Shareholders’ equityRNAC overview →